YSB(09885): Trustee purchased 100,000 shares under the stock incentive plan.

YSB (09885) announced that on January 7, 2025, in accordance with the trust arrangement between the company and the trustee, the trustee repurchased 100,000 shares of the company on the market at a total cost of HKD 571,000, with an average price of approximately HKD 5.71 per share. The announcement stated that the company's current stock price is lower than its intrinsic value and may not fully reflect the company's business prospects. Therefore, this provided a good opportunity for the trustee to repurchase the company's shares on the market to supplement the trust fund. Additionally, repurchasing shares under the stock incentive plan demonstrates the company's confidence in its business outlook and prospects, and can also serve as a way to attract talent and align the interests of key employees with the company's interests, promoting the long-term sustainable growth strategy of the group. As the largest digital comprehensive service platform in the Chinese extramural pharmaceutical industry, the group will continue to promote the healthy development of the industry through its efficient internet pharmaceutical distribution network and medical technology innovation methods, amid the rapid development of the internet medical industry, in order to better fulfill its mission of "making good medicine and good treatment accessible to all".